chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported symptoms on Sunday the 14th with a headache, cough, cold symptoms, sinus congestion, stuffy nose, and drainage. Patient is still congested, but other symptoms resolved.  On 3/17/21 - Patient was tested and results were given to her on the 18th showing she was positive for Covid19.
Patient received the 2nd dose of Shingrix 11 days prior to the 2 to 6 month window.
Pt states pain started in left leg around 3pm and became "excruciating" and by 9pm could not walk unassisted. Days later started in right leg and also spread to neck wrist and shoulder. Pt also had lightheadedness off and on during this time.
Pt reported on 09-12-09 at 9:30 AM noted raised, warm area on (L) arm where was vaccine given. Stated as day progressed noted itching under skin, increase whole body achy, felt feverish. Large raised, reddish purplish area noted near injection site 16 mm -> 12 mm increase raise 0.10 mm ->.20 mm  - took ZYRTEC that AM - No other treatment.
Vaccine was administered 03/29/2022 at 0924. Resident had no complaints of pain or illness at this time. Resident was found face down on floor at 0130 by staff. Resident was confused at noted to have a head contusion and skin tear to the right elbow. Vitals were as follows; temp101.1, heart rate 97, respirations 20, blood pressure 90/60 and O2 sat 98%. Residents last temp check was 97.9 at  2354 on 3/29/2022. Resident was transfered to the ER next door. He received a full work up and was then transfered to facility. DX of NSTEMI at transfer. Resident passed away facility. WBC 13.5. Troponin 2.210. Procalcitonin 1.2. Resident diagnosed as septic
Patient states that 2 days after he received the vaccinations he had a rash on both arms that had raised bumps but did not itch.
Information has been received from a nurse practitioner concerning an 18 year old female who on 10-MAR-2008 was vaccinated with a first dose of GARDASIL vaccine (lot # 659653/1448U) and on 5-MAY-2008 was vaccinated with a second dose of GARDASIL vaccine (lot # 659653/1448U). Concomitant therapy included hormonal contraceptives (unspecified). On unspecified date the patient experienced arm numbness. The patient sought unspecified medical attention.  It is unknown if patient experienced the event after the first or second dose. At the time of reporting the patient's arm numbness persisted. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 11/14/2008. Follow-up information was received from the nurse practitioner. It was reported that the patient was a female who was vaccinated with a first dose of GARDASIL vaccine intramuscularly into the left deltoid and with a second dose of GARDASIL vaccine intramuscularly into the right deltoid. The patient noted arm numbness after each injection and the affected area was from shoulder to elbow. At the time of reporting, the outcome was unknown. No further information was available.
Patient initially had redness and warmth at the injection site, this went away after a week.  Recently the patient has noticed some loss of mobility with the left shoulder accompanied with pain in the shoulder joint.
Pt reported feeling dizzy 5 minutes after receiving the flu shot. He denied any other problems such as difficulty breathing, sweating, etc. He sat in the waiting area for around 20 minutes and reported feeling better. He mentioned his blood pressure had been a little high earlier in the day. He walked around the store for around 10 minutes, came back and said he was ready to leave.
PT WOKE UP WITH LA RED, SWOLLEN, AND PAINFUL. SITE MEASURED ABOUT 40MM IN LENGTH AND WAS HOT TO TOUCH.
Rotator cuff tendinitis in right arm.  Ibuprofen , cold pack and warm patches. Resting.  Outcome: improvement over 4 days. Less pain, more range of motion.
Erythema/induration at injection site - still monitoring at day 4 post vaccine but continues to grow larger
9/26/08 parent states at 0530AM child had fever 102.9 and seizure activity noted for 5 minutes then child stopped breathing.  Airway cleared by dad by moving childs tongue and 2 breathes given then child began birthing.  Ambulance called and child transported to ER.
On 07/30/2021 - I went into A-fib, it lasted about 45 minutes, my heart rate was 177. I went to the urgent care, it was back in sinus rhythm. The urgent room sent me to the ER by ambulance -- blood work, EKG, they set me up on machines. On 08/092021 - 08/13/2021 - I had to wear a heart monitor for 2 weeks -- I had a irregular heart rate at least 600 or 700 times during those 2 weeks. It is the first and only time I have had A-fib and that lasted 45 minutes, that I am aware of. I am continuing to do treatments for A-fib.
Woke up in the middle of the night.  Could not bend the 3 middle fingers of my right hand and had a burning sensation from the tip of these fingers to my elbow.  This happened on 2 separate occasions, both at night. The events lasted about 20 minutes each and then resolved by themselves. The sole of my right foot has had burning sensations as well.  I have had continued problems with numbness/tingling of both hands, but worse in the right (the one i use all the time).  I have had issues with dizziness and balance (still do) ever since my first vaccine.  I did not go to the doctor as I just blew them off as something else, although not being able to bend my  fingers and the burning really scared me. The numbness/tingling persists as does the dizziness, now 6 months later.
Post vax, pt developed skin rash that was scattered erythema macular with central papules, few vesicular scabs.
Vaccine to someone who was less than 18 years old.; A spontaneous report was received from a healthcare professional (HCP) concerning a 16-year-old, female consumer who received Moderna's COVID-19 vaccine and experienced product administered to patient of inappropriate age.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 06 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection and experienced product administered to patient of inappropriate age.  No side effects were reported. No treatment information was provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The event, vaccine given to a patient less than 18-years-old, was considered resolved on 06 Jan 2021.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273, lot # 011J20A. There were no reported AEs associated with this case of product administered to patient of inappropriate age.
Patient called pharmacy and informed us of a delayed reaction to the covid vaccine.  Her complaint was "DELAYED REACTION  TO COVID VACCINE- SORENESS IN RIGHT ARM SINCE VACCINE ON 09/16/22. ALSO HAD RASH ON RIGHT TIGHT ON 09/21/22- WENT AWAY. NOW BACK AGAIN- COMPLAINS OF TERRIBLE JOINT PAINS- WORSE AS THE DAYS GO ON- SAYS PAIN IS WORSE WHEN SHE GETS COLD- NO KNOWN TEMPS- STATES RASH DOESN'T ITCH- JUST TENDER TO THE TOUCH"  according  to letter received on 10/06/22 at the pharmacy
Heartbeat was erratic at times - fluttering very fast.; Heartbeat was erratic at times - fluttering very fast.; Heartbeat was erratic at times - fluttering very fast.; This is a spontaneous report from a non-contactable consumer. A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 01Apr2021, the patient experienced heartbeat was erratic at times - fluttering very fast. The outcome of the event was unknown.     No follow up attempts are possible; information about lot number cannot be obtained.
Initial soreness in right arm followed by joint aches throughout the body.; Initial soreness in right arm followed by joint aches throughout the body.; Next, persistent extreme fatigue that persists to today; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 12:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included morbid obesity, osteoarthritis, penicillin allergy, adhesives allergy (dermatitis contact), and lupus erythematosus (lupus). The patient had received medication which was not specified within two weeks of vaccination for unknown indication and unknown if ongoing. The patient previously took cefalexin (KEFLEX), clindamycin (CLEOCIN), vancomycin (MANUFACTURER UNKNOWN), levofloxacin (LEVOQUIN), clindamycin (MANUFACTURER UNKNOWN) and colchicine (MANUFACTURER UNKNOWN) and experienced drug allergy to these. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 22Mar2021 at 12:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 13:00, the patient experienced initial soreness in right arm followed by joint aches throughout the body. Next, persistent extreme fatigue that persisted to the day of report. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events initial soreness in right arm followed by joint aches throughout the body; next, persistent extreme fatigue that persisted to the day of report was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
p/ pt vax 4/20 then on 6/3 lab evaluations revealed titers of 0.04. 6/5  pt recv 3rd vax. then it was rpt pt exposed to a child at home & never seroconverted. addl info recv pt tested & still came back seronegative.
Psoriasis like rash on legs; Rash across whole body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Apr2021 12:00 (Lot number: EW0172) at the age of 52 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ZYRTEC ALLERGY; NEXIUM [ESOMEPRAZOLE SODIUM]. Vaccination history included: Pfizer (DOSE 1, SINGLE, Batch/Lot No: EP7533, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 31Mar2021, when the patient was 52 years old, for covid-19 immunization. The following information was reported: PSORIASIS (non-serious), outcome "recovered with sequelae", described as "Psoriasis like rash on legs"; RASH (non-serious), outcome "recovered with sequelae", described as "Rash across whole body". The events "psoriasis like rash on legs" and "rash across whole body" were evaluated at the physician office visit. Therapeutic measures were taken as a result of psoriasis, rash.  Additional information: No other vaccine in four weeks. Rash across whole body. Psoriasis like rash on legs. Symptoms started with 2nd dose but 3rd dose caused systematic symptoms which have required steroid treatment. Ae resulted in: (Doctor or other healthcare professional office/clinic visit). Patient had no covid prior vaccination. patient was not tested for covid post vaccination. patient had no known allergies. Patient had no other medical history. No other vaccine in four weeks.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101826033 similar report from same reporter
p/vax pt exp local 8x6cm pink indurated area at inj site; pt recovering
This is a 93-year-old male patient that presents to the ER today with complaints of cough, fever along with vomiting x2 days.  The patient states he only vomited once and that was 2 days ago.  Today he denies any chest pain, shortness of breath, wheezing, abdominal pain or nausea and vomiting.  He denies any diarrhea.  He did call his primary care provider who felt that he should be evaluated in the ER today due to his age.  The patient is alert, cooperative and oriented x3.  He does appear nontoxic.  His son is at the bedside.  He does have a history of pacemaker, hypertension, sleep apnea, coronary artery disease and hyperlipidemia. Associated Symptoms: chills, cough, fever, nausea, URI symptoms, vomiting
Headache, dehydration very thirsty all the time, eye pain, dizziness
Dosage of YF vaccine was not verified by administrator. 5 dose vial was diluted with 0.6mL's of sodium chloride and administered to the patient. Patient was taken to the Hosp for evaluation and released.
Student was vaccinated on a Friday, and per mother child started complaining of crushing chest pain on Saturday. Mom brought child to the hospital on Saturday and the child was diagnosed with premature ventricular contractions. Mom to follow-up with pediatric cardiologist.
This spontaneous report as received from a pharmacist refers to a 60 year old male patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot# and expiration date were not reported). Approximately in August 2014 the patient experienced injection site reaction: redness and swelling at the injection site of the ZOSTAVAX and unspecified period of time after receiving ZOSTAVAX. The reporter believed that the injection site redness and swelling developed  "within 2 days" of receiving ZOSTAVAX. The reporter was not aware of any treatment that ws provided and he stated that there was a nurse practitioner in the patient's family. On Saturday 09-AUG-2014, the patient's wife contacted the pharmacist and informed him that the injection sites of her husband were "okay", so the reporter believed that the injection site redness and swelling of the patient were resolved and the patient recovered. The patient did not seek any medical attention. The relatedness between the event of "redness and swelling at the injection site" and ZOSTAVAX was not reported. This is the one of two reports received from the same reporter (MARRS#1409USA001292 the patients wife's case). Additional information has been requested.
This spontaneous report was received from a pharmacy technician and refers to a unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M033583 with an expiration date 14-APR-2019 for prophylaxis (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of GARDASIL 9 experienced the temperature excursion of 1 degrees Celsius for 93 hours. A digital data logger was involved. There was no previous temperature excursion.  Product quality complaint (PQC) was not reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1703USA013107: US-009507513-1703USA013108: US-009507513-1703USA013106:
herpes zoster; postherpetic neuralgia; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not provided.   On an unspecified date, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (strength, dose, route of administration, lot # and expiration date were not reported) for routine health maintenance and the prevention of shingles (herpes zoster).  On an unspecified date, after receiving the vaccine, the patient suffered herpes zoster and postherpetic neuralgia. As a result of these symptoms, Plaintiff was seen and treated by medical providers and was still under their care. As a direct and proximate result of defective zoster vaccine live (ZOSTAVAX), Plaintiff's symptoms have resulted in physical limitations not present prior to using the product. Plaintiffs also experience mental and emotional distress due to resulting physical limitations and seriousness of Plaintiffs' condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), Plaintiffs sustained severe and permanent personal injuries. Further, as a tragic consequence of wrongful conduct, Plaintiffs suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Defendants' conduct, Plaintiffs have suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.   The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experienced was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected
Patient was given a flu vaccine instead of the shingles vaccine she came in for. She did end up receiving the SHINGRIX shot as well. Pt was given the flu vaccine at another facility about 4 weeks ago
20 minutes after receiving the vaccine I got a hot flush and a numb throat. I felt dizzy and medical staff gave me 25mg of Benadryl and apple juice. I waited another 15 minutes and I felt tingling in the tongue. Dr observed me Pulse and Bp were low to start and became elevated. I received another 25mg of Benadryl and I was observed for another 20 minutes. I woke up that evening feeling tired. I woke up in a few hours feeling like I was beaten up joint pain and muscle pain.  Muscle tremors were worse than normal it was difficult to walk. Low grade fever and headache. This lingered for a few days. I developed mouth sores after days and still had a headache. Arm pain and aches and pains. Total time feeling poorly  was 9 days. I visited an allergist on the advice of facility, allergist advised Zyrtec before next dose. Second dose caused similar symptoms with severe aches and pains. I had trouble getting up or moving. Tremors on the right side leg and arm were markedly worse than normal. Instability and fatigue lasted three weeks. Mood swings were unusual.
Local Rxn began within 2 hrs of vaccination has occurred in prior years. 6 cm swelling (L) deltoid, pain. Tx PEPCID, BENADRYL, CLARITIN, MEDROL, ice.
Left thigh red, swollen with difficulty walking 24hours after injection was given. Temp 98.9. Plus soft tissue swelling.
Patient received Pfizer vaccine as second dose on 12/09/21  after having received Moderna vaccine as first dose on 11/08/21. No issues noted or reported by patient at time of vaccination or after observation period. Provider spoke to patient who was okay with situation. He did not voice any questions or concerns.
Information has been received from a licensed practical nurse concerning an 8 year old female with no allergies or medical history who on 15-JAN-1999 was vaccinated with a dose of Varivax (lot # 628036/1251H). On 24-MAY-2006, the patient began to develop a rash. She presented to the physician's office on 26-MAY-2006 and was noted to have more itchy lesions all over her body. She was afebrile. The child's mother had been treating her with BENADRYL 25 mg daily. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. It was also noted that the patient's sister had the chickenpox first, but the reporter was unsure if the sibling had ever been vaccinated with Varivax. A product quality complaint was not involved. Additional information has been requested.
Starting 05/26/2022, it started with a cough. Normally I would have a cough due to the cancer and COPD, but not that much. I was coughing up phlegm (thinking I was having a cold). Normally I go to the gym every day and I felt maybe I was a little over worked that day. However, I had an infusion the next day so I decided to test myself just in case and I was positive. I am very tired but the cough has subsided at this point. I normally don't sleep much so I didn't think to much about it but I have been extra sleepy lately and have actually had the best sleep I've had in awhile. I had a slight headache and took Tylenol to resolve, but no fever or aches/pains. I had very mild symptoms. I was treated with monoclonal antibodies yesterday on 06/02/2022.
Throat and tongue  real pain then to chest pain then to bad headache then next day sweated all night long and no sleep.
Severe L arm pain starting the day of injection. Additionally, L arm weakness. Worse pain and weakness for the first week after injection, but pain and weakness still present at the time of submission (>2 weeks from injection)
Patient had a redness at site of injection after 2 days then it swelling for couples day and ended with itching at site of injection. Patient visited emergency department and doctor prescribe BENADRYL 25 mg.
Patient called 2 days after Spikevax vaccination and stated that her arm was red, swollen, and looked like it had developed cellulitis. She also said the area was itchy, but not painful. She has received Moderna Covid vaccines in the past with no problems. She had not tried anything to resolve her reaction at the time she had called. I recommended that she try icing the area until the swelling went down, then use heat on it for healing. I also recommended an anti-inflammatory. I told her to take pictures of the area and call her provider to inform them of the reaction. I also told her that if it did not resolve within the next few days or if it gets any worse to be seen by a medical provider.
Pt slept all day /p vax /w DTP, when pt woke up had seizure @ 7pm. Pt taken to ER, T104+ (R), bilateral otitis media, pt admit to hospital. DX: convulsion due to high temp.
2.5-3cm redness with bruising. 1 cm induration palpable (L) anterior thigh.
Nausea, upper g.i. cramping, headache, followed by aching whole body muscle pain, chills, headache, left arm pain to elbow
Vaccinated  8/26/2021, 3/9/2021, 2/16/2021. Hospitalized with COVID 1/7/22
Patient had adverse drug reaction of Guillain Barre. Discharge summary states Dysphagia, hypotonia, reflex decreased, constipation, ataxia. msv Follow-up: Cough, runny nose 1 week prior to illness. Progressing to being unable to walk - admitted 12-2-05.
Patient came for nurse only visit to received influenza. Nurse gathered immunization but unable to administered so she gave to another nurse who did not verify age and product. Patient received 0.5 ml instead of 0.25 ml.